Robert (Max) Johnston Buys 162,161 Shares of INOVIQ Ltd (ASX:IIQ) Stock

INOVIQ Ltd (ASX:IIQ) insider Robert (Max) Johnston acquired 162,161 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were acquired at an average price of A$0.35 ($0.22) per share, for a total transaction of A$56,756.35 ($35,921.74).

INOVIQ Stock Performance

The company has a debt-to-equity ratio of 2.02, a current ratio of 7.07 and a quick ratio of 9.52. The firm has a market capitalization of $47.40 million, a price-to-earnings ratio of -6.02 and a beta of 2.04.

About INOVIQ

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample.